Published in

Acoustical Society of America, The Journal of the Acoustical Society of America, 4(125), p. 2554-2554

DOI: 10.1121/1.4783663

Links

Tools

Export citation

Search in Google Scholar

Targeted ultrasound contrast agents for the imaging of biofilm infections.

Journal article published in 2009 by Pavlos Anastasiadis, Kristina Mojica ORCID, Michelle L. Matter, John S. Allen
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

Targeted ultrasound contrast agents (UCA) offer a novel, potential method for diagnostic imaging of biofilm infections. Currently, there is no established method for molecular imaging of in vitro biofilm infections with any type of modality. For infective endocarditis, the case of biofilm formation on damaged or diseased heart valves, an early diagnostic method might greatly reduce the associated high mortality rate. Fluorescently labeled lectins were used with targeted ultrasound contrast agents in conjunction with epifluorescence microscopy and time-resolved scanning acoustic microscopy for visualization and characterization of the extracellular polymeric substances (EPS) of two types of infectious biofilms (Staphylococcus aureus and Pseudomonas aeruginosa). Noninvasive acoustic measurements of the biofilms were conducted at high-frequency (100 MHz) with a time-resolved scanning acoustic microscope. Measurements of the reflection and transmission coefficients, over a broad frequency spectrum for a range of biofilm growth stages in both, the presence and absence of targeted UCA were obtained. The biofilm morphology and structure were also investigated with acoustic microscopy as a function of growth. [This work was supported by the National Institutes of Health Grants NIH 2 P20 RR016453-05A1 and NIH 2 G12 RR0030161-21.].